Ascendia Pharmaceutical Solutions Puts Customers First During Formulation Development & Manufacturing

May 18, 2026 2:50:25 PM

Ascendia Pharmaceutical Solutions Founder and CEO Named EY Entrepreneur Of The Year® 2026 New Jersey Finalist

Apr 24, 2026 6:14:51 PM

SEDDS/SNEDDS – A Self Emulsifying Technology for Delivery of an Array of Small and Large Molecules

Apr 29, 2025 1:05:33 PM

Ascendia Pharmaceutical Solutions Expands Business Development Team

Feb 20, 2025 5:03:45 PM

Ascendia Pharmaceuticals Named to Inc. 5000 List for Third Consecutive Year

Sep 8, 2022 12:00:00 AM

Steps to Overcome Challenges Associated with Biologic Formulation Development

Aug 22, 2022 12:00:00 AM

Ascendia Pharmaceuticals Included in 2022 United States Life Sciences Report

Jul 7, 2022 12:00:00 AM

Ascendia Pharmaceuticals Provides Perspective on Life Science Market During CPHI North America

Jun 27, 2022 12:00:00 AM

Ascendia CEO Presents on Gene Therapy Drug Delivery Technologies at SAPA Event

Jun 20, 2022 12:00:00 AM

How Various Clinical Study Stages Influences Oral Formulation Approach

Apr 4, 2022 12:00:00 AM

Ascendia to Attend DCAT Week

Mar 11, 2022 12:00:00 AM

Developing an Effective Lipid Nanoparticle Formulation Process for Small Molecule and Biologicals Delivery

Feb 21, 2022 12:00:00 AM